Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients

Ayelet Ollech1, Michal Solomon, Amir Horev

  • 1Department of Dermatology, Rabin Medical Center, Beilinson Hospital Petach Tikva, Petach Tikva 49100, Israel.

Acta Dermato-Venereologica
|November 18, 2020
PubMed

Insights

Miltefosine shows promise as an effective and safe oral treatment for pediatric Old World cutaneous leishmaniasis. This study found an 80% complete response rate in children with Leishmania tropica or Leishmania major infections.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Tropical Medicine

Background:

  • Cutaneous leishmaniasis presents significant treatment challenges in children.
  • Old World cutaneous leishmaniasis requires effective and safe therapeutic options for pediatric patients.

Purpose of the Study:

  • To evaluate the efficacy and safety of miltefosine for treating Old World cutaneous leishmaniasis in children.
  • To assess treatment outcomes in pediatric patients with Leishmania tropica and Leishmania major infections.

Main Methods:

  • A multicenter retrospective review was conducted on 10 pediatric patients (≤18 years) treated with miltefosine in Israel.
  • Data collected included patient age, Leishmania species, treatment duration, follow-up period, treatment response, and adverse effects.

Main Results:

  • Complete response to miltefosine was observed in 80% (8/10) of pediatric patients.
  • Treatment failure occurred in 20% (2/10) of cases.
  • Adverse effects associated with miltefosine treatment were minimal.

Conclusions:

  • Oral miltefosine appears to be an effective and safe treatment option for pediatric Old World cutaneous leishmaniasis caused by Leishmania tropica or Leishmania major.
  • Further research is necessary to definitively establish miltefosine's role in treating pediatric cutaneous leishmaniasis.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
94
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
280